Daniel P. Petrylak, Phillip H. Kuo, Gwenaelle Gravis, marcus hacker, Xin Gao, Ravindran Kanesvaran, Caroline Wilmot, Jiawei Duan, Rafael Caparica, Tanya B. Dorff. "The LuxAR-02 phase II study of luxdegalutamide in combination with [
                    <sup>177</sup>
                    Lu]Lu-PSMA-617 in patients with prostate-specific membrane antigen (PSMA)–positive metastatic castration resistant prostate cancer (mCRPC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.tps278